Editor's Note Reducing low-value testing before cataract surgery was associated with cost savings for financially capitated healthcare systems, but it was also associated with losses for fee-for-service healthcare systems, which could be a barrier to eliminating low-value care, this study finds. Of 1,054 patients (469 intervention, 585 controls) included in…

Read More

Editor's Note The Food & Drug Administration (FDA) on March 5 identified the recall by RVO 2.0, Inc (Aliso Viejo, California) of its Raindrop near vision inlay as Class I, the most serious. All lots of the inlay are being recalled because data from the post-approval study showed an increased…

Read More

Editor's Note The Food & Drug Administration (FDA) on October 24 classified Alcon Research’s recall of its CyPass Micro-Stent Systems as Class I, the most serious. The recall was initiated because of the risk of corneal endothelial cell loss with the system, which is used in conjunction with cataract surgery…

Read More

Editor's Note The Food & Drug Administration (FDA) on October 23 issued a Safety Communication on the increased risk of corneal haze associated with the Raindrop Near Vision Inlay, which is surgically implanted in the cornea of one eye to improve near vision. The notice is to alert eye care…

Read More

Editor's Note The Food & Drug Administration (FDA) on October 22 announced the recall by Promise Pharmacy (Palm Harbor, Florida) of one lot of Prednisolone and Gatifloxacin Ophthalmic Solution 1%/0.5% sterile, 3 mL vials (Lot Number 09042018@2, Exp 12/03/2018). The recall was issued because the product was found to have…

Read More

Editor's Note In this study, cataract surgery was associated with a patient’s reduced subsequent risk of being in a serious traffic crash as a driver. This analysis of 559,546 patients who had cataract surgery in at least one eye found that the crash rate decreased from 2.36 to 2.14 per…

Read More

Editor's Note The Food & Drug Administration (FDA) on June 14 issued a Safety Alert for compounded drugs containing triamcinolone and moxifloxacin by Guardian Pharmacy Services (Dallas, Texas). At least 43 patients have reported adverse events after receiving eye injections of the compounded triamcinolone and moxifloxacin drug during cataract surgery.…

Read More

Editor's Note The American Association of Nurse Anesthetists (AANA) on March 19 expressed strong opposition to the decision by insurer Anthem, Inc, that ophthalmologists assume responsibility for the administration of anesthesia and patient monitoring during cataract procedures. “Ophthalmologists are no more qualified to administer anesthesia than CRNAs are to perform…

Read More

Editor's Note Most patients who had cataract surgery from 2001 to 2014 did so at ambulatory surgery centers (ASCs) compared with hospital outpatient departments (HOPDs), this study finds. In this analysis of 369,320 patients who had 531,325 cataract surgeries, the proportion performed at ASCs increased from 43.6% in 2001 to…

Read More

Editor's Note National data show a large shift in cataract surgeries from hospitals to less expensive ambulatory surgery centers (ASCs), where care can be delivered faster and closer to home, this study finds. From 2001 to 2014, the proportion of cataract surgeries performed at ASCs increased steadily from 43.6% to…

Read More